X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (98) 98
humans (82) 82
cardiac & cardiovascular systems (64) 64
animals (54) 54
heart failure (38) 38
male (31) 31
oxidative stress (31) 31
female (25) 25
heart-failure (24) 24
cancer (23) 23
biochemistry & molecular biology (22) 22
cardiotoxicity (22) 22
mice (20) 20
pharmacology & pharmacy (20) 20
cardiology (18) 18
echocardiography (17) 17
chemotherapy (16) 16
risk factors (16) 16
expression (15) 15
adult (14) 14
breast-cancer (14) 14
cardiomyopathy (14) 14
cell biology (14) 14
middle aged (14) 14
signal transduction (14) 14
left-ventricular dysfunction (13) 13
neoplasms - drug therapy (13) 13
analysis (12) 12
antineoplastic agents - adverse effects (12) 12
metabolism (12) 12
oncology (12) 12
oxidation-reduction (12) 12
peripheral vascular disease (12) 12
physiological aspects (12) 12
research (12) 12
aged (11) 11
care and treatment (11) 11
dysfunction (11) 11
myocardium - metabolism (11) 11
myocytes, cardiac - drug effects (11) 11
nitric oxide (11) 11
prognosis (11) 11
cardiac dysfunction (10) 10
cardiomyocytes (10) 10
drug resistance in microorganisms (10) 10
endocrinology & metabolism (10) 10
health aspects (10) 10
mice, inbred c57bl (10) 10
mitochondria (10) 10
molecular-mechanisms (10) 10
nitric-oxide synthase (10) 10
physiology (10) 10
proteins (10) 10
anthracyclines (9) 9
calcium - metabolism (9) 9
contractility (9) 9
gene expression (9) 9
glutathione (9) 9
heart (9) 9
heart diseases (9) 9
hematology (9) 9
myocytes, cardiac - metabolism (9) 9
research article (9) 9
activation (8) 8
article (8) 8
breast cancer (8) 8
cancer therapies (8) 8
congestive-heart-failure (8) 8
dilated cardiomyopathy (8) 8
disease (8) 8
dose-response relationship, drug (8) 8
heart failure - physiopathology (8) 8
hypertension (8) 8
in-vivo (8) 8
medicine & public health (8) 8
mortality (8) 8
mrp2 (8) 8
myocarditis (8) 8
nitric-oxide (8) 8
nitroxyl (8) 8
review (8) 8
adolescent (7) 7
anthracycline-induced cardiotoxicity (7) 7
biomarkers (7) 7
cardiovascular diseases - chemically induced (7) 7
cells (7) 7
disease models, animal (7) 7
doxorubicin (7) 7
drug therapy (7) 7
heart - drug effects (7) 7
inflammation (7) 7
kinases (7) 7
management (7) 7
multidisciplinary sciences (7) 7
myocardial contraction - drug effects (7) 7
outcomes (7) 7
phosphorylation (7) 7
prevalence (7) 7
rats (7) 7
abridged index medicus (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Heart Failure, ISSN 1388-9842, 03/2019, Volume 21, Issue 3, pp. 272 - 285
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 6/2012, Volume 133, Issue 2, pp. 511 - 521
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 04/2014, Volume 16, Issue 4, pp. 358 - 366
Aims Doxorubicin is widely used against cancer; however, it can produce heart failure (HF). Among other hallmarks, oxidative stress is a major contributor to... 
Doxorubicin cardiotoxicity • Ranolazine • Heart failure • Oxidative stress • Na+ | Doxorubicin cardiotoxicity • Ranolazine • Heart failure • Oxidative stress • Na | Heart failure | Oxidative stress | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | MYOCYTES | NITROSATIVE STRESS | ISOLATED RAT HEARTS | CARDIOTOXICITY | EUROPEAN-SOCIETY | Ranolazine | DIASTOLIC DYSFUNCTION | Doxorubicin cardiotoxicity | CALCIUM | Na+ | HEART-FAILURE ASSOCIATION | INHIBITOR | Antibiotics, Antineoplastic - toxicity | Reactive Oxygen Species - metabolism | Cardiotoxicity - diagnostic imaging | Ventricular Dysfunction, Left - chemically induced | Atrial Natriuretic Factor - genetics | Reverse Transcriptase Polymerase Chain Reaction - methods | Ultrasonography | Acetanilides - therapeutic use | Real-Time Polymerase Chain Reaction | Cardiotoxicity - prevention & control | Blotting, Western - methods | Natriuretic Peptide, Brain - genetics | Myocytes, Cardiac - cytology | Mice, Inbred C57BL | RNA, Messenger - genetics | Oxidative Stress - genetics | Piperazines - therapeutic use | Enzyme Inhibitors - therapeutic use | Doxorubicin - toxicity | Sodium - blood | Ventricular Dysfunction, Left - prevention & control | Ventricular Dysfunction, Left - metabolism | Matrix Metalloproteinase 2 - genetics | Poly(ADP-ribose) Polymerases - metabolism | Animals | Connective Tissue Growth Factor - genetics | Mice | Oxidative Stress - drug effects
Journal Article
European journal of heart failure, ISSN 1388-9842, 11/2017, Volume 19, Issue 11, pp. 1361 - 1378
Journal Article